Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus.
about
A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.Pediatric antiretroviral therapy.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Investigation of oral bioavailability and brain distribution of the Ind(8)-Val conjugate of indinavir in rodents.
P2860
Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Protease inhibitors: a therape ...... human immunodeficiency virus.
@en
type
label
Protease inhibitors: a therape ...... human immunodeficiency virus.
@en
prefLabel
Protease inhibitors: a therape ...... human immunodeficiency virus.
@en
P2093
P1476
Protease inhibitors: a therape ...... human immunodeficiency virus.
@en
P2093
Coulston DR
Garrison MW
Lewis JS 2nd
Terriff CM
P304
P356
10.1016/S0149-2918(97)80110-5
P577
1997-03-01T00:00:00Z